Sunday, August 10, 2008
NCBC Industrial Fellowship Update
The North Carolina Biotechnology Center (NCBC) just announced that the following five North Carolina life sciences companies have been chosen as sponsors for the inaugural year of the NCBC Industrial Fellowship Program:
Affinergy, Inc. (Durham, NC): develops site-specific biological delivery systems, such as constructing bifunctional peptide linkers that can selectively immobilize proteins, cells, and therapeutics onto biomaterial surfaces.
Aldagen, Inc. (Durham, NC): a biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs with four product candidates in clinical trials.
BASF Plant Science LLC (RTP, NC): BASF Plant Science (BPS) was founded in 1998 as a multinational plant biotechnology organization performing research and development aimed at optimizing crops for efficient agriculture, renewable raw materials for specialty products, and to provide healthier nutrition for humans and animals.
Targacept, Inc. (Winston-Salem, NC): a clinical-stage biopharmaceutical company that discovers and develops NNR Therapeutics , a new class of drugs for the treatment of central nervous system diseases and disorders.
Tengion, Inc. (Winston-Salem, NC): a clinical-stage biotechnology company, is a leader in developing neo-organs and tissues derived from a patient's own (autologous) cells.
Applications will be accepted for these fellowships through August 22nd, 2008. Visit the program website for details about the program, the online application form, and submission instructions.
* Candidates must complete all items on the application form and indicate a specific fellowship opportunity for which they are applying.
* Candidates will be required to attach a CV or resume with the application before submitting via e-mail as instructed.
* A candidate may apply for more than one fellowship if their qualifications and career interests are applicable to multiple opportunities, but these must be submitted as separate complete applications.
* Candidate applications will be collected by the NCBC and forwarded to the sponsor companies. Companies will select the candidates to be hired as NCBC Fellows.
For questions, contact:
Shobha Parthasarathi, Ph.D.
Technology Development Director
Business and Technology Development Program
North Carolina Biotechnology Center
Tuesday, August 5, 2008
Live Podcasts from the 2008 BIO International Convention
I found some podcasts really interesting, good to catch up the upcoming industry trends and hot technologies.
INDUSTRY TRENDS interviews
Building on Success: Where the Industry is Heading After 2008
Global Biotechnology Leader
Ernst & Young
The State of the Biotech Industry
G. Steven Burrill
Chief Executive Officer
Burrill & Company
Will the US Lose Its Lead in Biotech Manufacturing?
Peter Watler, PhD
Principal Consultant & CTO
JM Hyde Consulting, Inc.
EMERGING TECHNOLOGIES interviews
Nanotechnology: A Disruptive Technology in Medicine
Prof. Thomas Rademacher, MD, PhD
Challenges in Quality Control for Personalized Medicines
Stephan Krause, PhD
Director, Quality Control
To listen to these podcasts, please go to the Biopharmainternational.
Subscribe to Posts [Atom]